A direct comparison of intravenous enoxaparin with unfractionated heparin in primary percutaneous coronary intervention (from the ATOLL trial).

A direct comparison of intravenous enoxaparin with unfractionated heparin in primary percutaneous coronary intervention (from the ATOLL trial). Publié dans American Journal of Cardiology, le 01 novembre 2013. En savoir plus en consultant le site. Auteurs : Collet JP, Huber K, Cohen M, Zeymer U, Goldstein P, Pollack C Jr, Silvain J, Henry P, Varenne O, Carrié…

Optimal time for catheterization in NSTE-ACS patients with impaired renal function: insights from the ABOARD Study.

Optimal time for catheterization in NSTE-ACS patients with impaired renal function: insights from the ABOARD Study. Publié dans International Journal of Cardiology, le 10 septembre 2013. En savoir plus en consultant le site. Auteurs : Barthélémy O, Cayla G, Silvain J, O'Connor SA, Bellemain-Appaix A, Beygui F, Sideris G, Varenne O, Collet JP, Vicaut E, Montalescot G;…

Identification of poor response to P2Y12 inhibitors in ACS patients with a new ELISA-based vasodilator-associated stimulated phosphoprotein (VASP) phosphorylation assay.

Identification of poor response to P2Y12 inhibitors in ACS patients with a new ELISA-based vasodilator-associated stimulated phosphoprotein (VASP) phosphorylation assay. Publié dans Thrombosis and Haemostasis, le 08 août 2013. En savoir plus en consultant le site. Auteurs : Abtan J, Silvain J, Kerneis M, O'Connor SA, Barthélémy O, Vignalou JB, Beygui F, Brugier D, Collet JP, Montalescot…